Developing disease activity and response criteria in connective tissue disease-related interstitial lung disease

Lesley Ann Saketkoo, Eric Lawrence Matteson, Kevin K. Brown, James R. Seibold, Vibeke Strand

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The interstitial lung diseases (ILD) are a group of heterogeneous diseases that exert significant morbidity and mortality in connective tissue diseases (CTD). There is no consensus on measures of disease activity or therapeutic responsiveness, which hampers effective drug development and regulatory evaluation of candidate therapies. The CTD-ILD Special Interest Group represents an international multidisciplinary effort to identify consensus on criteria to measure disease activity and therapeutic response in CTD-ILD. We summarize the design of the studies we are conducting and progress leading to the OMERACT 10 and 2010 EULAR meetings.

Original languageEnglish (US)
Pages (from-to)1514-1518
Number of pages5
JournalJournal of Rheumatology
Volume38
Issue number7
DOIs
StatePublished - Jul 2011

Fingerprint

Connective Tissue Diseases
Interstitial Lung Diseases
Public Opinion
Therapeutics
Morbidity
Mortality
Pharmaceutical Preparations

Keywords

  • Inflammatory myopathy
  • Interstitial lung disease
  • Outcome measures
  • Response criteria
  • Rheumatoid arthritis
  • Scleroderma

ASJC Scopus subject areas

  • Rheumatology
  • Immunology
  • Immunology and Allergy

Cite this

Developing disease activity and response criteria in connective tissue disease-related interstitial lung disease. / Saketkoo, Lesley Ann; Matteson, Eric Lawrence; Brown, Kevin K.; Seibold, James R.; Strand, Vibeke.

In: Journal of Rheumatology, Vol. 38, No. 7, 07.2011, p. 1514-1518.

Research output: Contribution to journalArticle

Saketkoo, Lesley Ann ; Matteson, Eric Lawrence ; Brown, Kevin K. ; Seibold, James R. ; Strand, Vibeke. / Developing disease activity and response criteria in connective tissue disease-related interstitial lung disease. In: Journal of Rheumatology. 2011 ; Vol. 38, No. 7. pp. 1514-1518.
@article{c5f0835d82a543a0ae4e6d30ecfacc4b,
title = "Developing disease activity and response criteria in connective tissue disease-related interstitial lung disease",
abstract = "The interstitial lung diseases (ILD) are a group of heterogeneous diseases that exert significant morbidity and mortality in connective tissue diseases (CTD). There is no consensus on measures of disease activity or therapeutic responsiveness, which hampers effective drug development and regulatory evaluation of candidate therapies. The CTD-ILD Special Interest Group represents an international multidisciplinary effort to identify consensus on criteria to measure disease activity and therapeutic response in CTD-ILD. We summarize the design of the studies we are conducting and progress leading to the OMERACT 10 and 2010 EULAR meetings.",
keywords = "Inflammatory myopathy, Interstitial lung disease, Outcome measures, Response criteria, Rheumatoid arthritis, Scleroderma",
author = "Saketkoo, {Lesley Ann} and Matteson, {Eric Lawrence} and Brown, {Kevin K.} and Seibold, {James R.} and Vibeke Strand",
year = "2011",
month = "7",
doi = "10.3899/jrheum.110281",
language = "English (US)",
volume = "38",
pages = "1514--1518",
journal = "Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology",
number = "7",

}

TY - JOUR

T1 - Developing disease activity and response criteria in connective tissue disease-related interstitial lung disease

AU - Saketkoo, Lesley Ann

AU - Matteson, Eric Lawrence

AU - Brown, Kevin K.

AU - Seibold, James R.

AU - Strand, Vibeke

PY - 2011/7

Y1 - 2011/7

N2 - The interstitial lung diseases (ILD) are a group of heterogeneous diseases that exert significant morbidity and mortality in connective tissue diseases (CTD). There is no consensus on measures of disease activity or therapeutic responsiveness, which hampers effective drug development and regulatory evaluation of candidate therapies. The CTD-ILD Special Interest Group represents an international multidisciplinary effort to identify consensus on criteria to measure disease activity and therapeutic response in CTD-ILD. We summarize the design of the studies we are conducting and progress leading to the OMERACT 10 and 2010 EULAR meetings.

AB - The interstitial lung diseases (ILD) are a group of heterogeneous diseases that exert significant morbidity and mortality in connective tissue diseases (CTD). There is no consensus on measures of disease activity or therapeutic responsiveness, which hampers effective drug development and regulatory evaluation of candidate therapies. The CTD-ILD Special Interest Group represents an international multidisciplinary effort to identify consensus on criteria to measure disease activity and therapeutic response in CTD-ILD. We summarize the design of the studies we are conducting and progress leading to the OMERACT 10 and 2010 EULAR meetings.

KW - Inflammatory myopathy

KW - Interstitial lung disease

KW - Outcome measures

KW - Response criteria

KW - Rheumatoid arthritis

KW - Scleroderma

UR - http://www.scopus.com/inward/record.url?scp=79959990773&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959990773&partnerID=8YFLogxK

U2 - 10.3899/jrheum.110281

DO - 10.3899/jrheum.110281

M3 - Article

VL - 38

SP - 1514

EP - 1518

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 7

ER -